Creo Medical Group PLC (AIM:CREO)

Market Cap	55.02M +11.6%
Revenue (ttm)	6.00M +50.0%
Net Income	5.30M
EPS	0.01
Shares Out	449.14M
PE Ratio	10.38
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	127,140
Open	12.03
Previous Close	12.25
Day's Range	12.00 - 12.47
52-Week Range	9.52 - 18.50
Beta	0.91
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 1, 2026

About Creo Medical Group

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develops CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. It also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needle ablati...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 104
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: CREO

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 25, 2026

Data Sources Report a data error